Trade NUVALENT CL A ORD - NUVL CFD
What is NUVALENT CL A ORD (NUVL)?
Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted therapies for cancer. The company employs a precision medicine approach to develop treatments aimed at specific genetic drivers of cancer, intending to improve patient outcomes. Nuvalent's pipeline includes small molecule inhibitors designed to address mutations and pathways involved in tumor growth and resistance mechanisms. The company engages in research collaborations and clinical trials to advance its drug candidates through regulatory approval processes. Nuvalent operates within the biotechnology sector, contributing to the development of innovative cancer therapies. Its activities encompass drug discovery, clinical development, and regulatory strategy.
NUVALENT CL A ORD Stock Price Today: Live Overview
The price today is shaped by NUVALENT CL A ORD's market movements, with the latest price at $104.24. It has traded within a daily range of $101.81 to $106.21, showing a daily change percentage of -1.9415%.
FAQ: NUVALENT CL A ORD (NUVL)
What is the current price of NUVL stock?
The latest price for NUVALENT CL A ORD is $104.24.
Does NUVL pay dividends?
NUVALENT CL A ORD does not pay dividends.
Does NUVL have a formal corporate presence or regional headquarters in the UAE?
NUVALENT CL A ORD operates via partners and distributors in the UAE without a registered office or subsidiary.
What is NUVL best known for?
NUVALENT CL A ORD is most famous for its work in oncology drug development.
What assets are typically shown together with NUVL?
Commonly shown alongside NUVL: Pacific Biosciences of California Inc, Heritage Insurance Holdings Inc, Neurocrine
Latest shares articles



